Volume 207, Issue 3
1 February 2013
Cover image
Cover image
On the cover: A histological section of lung of a mouse six days after being infected with influenza A virus (A/PR8), showing peribronchiolar and interstitial mononuclear inflammatory cell infiltrates. Hematoxylin and eosin stain, original magnification X 25). (See Taylor et al, pp 501–10).
ISSN 0022-1899
EISSN 1537-6613
Issue navigation
Volume 207, Issue 3, 1 February 2013
EDITORIAL COMMENTARIES
Vitamin D: An Adjunct to Antiretroviral Therapy?
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 373–375, https://doi.org/10.1093/infdis/jis697
Reducing Uncertainty About the Public Health Implications of Escherichia coli Serogroup O104:H4
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 376–377, https://doi.org/10.1093/infdis/jis706
MAJOR ARTICLES AND BRIEF REPORTS
HIV/AIDS
Vitamin D Status and Incidence of Pulmonary Tuberculosis, Opportunistic Infections, and Wasting Among HIV-Infected Tanzanian Adults Initiating Antiretroviral Therapy
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 378–385, https://doi.org/10.1093/infdis/jis693
Low Bone Mineral Density, Regardless of HIV Status, in Men Who Have Sex With Men
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 386–391, https://doi.org/10.1093/infdis/jis687
Human Papillomavirus Genotype Attribution and Estimation of Preventable Fraction of Anal Intraepithelial Neoplasia Cases Among HIV-Infected Men Who Have Sex With Men
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 392–401, https://doi.org/10.1093/infdis/jis694
Immune Response to Hepatitis B Virus Vaccination Among HIV-1 Infected And Uninfected Adults in Kenya
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 402–410, https://doi.org/10.1093/infdis/jis695
Association of BST-2 Gene Variants With HIV Disease Progression Underscores the Role of BST-2 in HIV Type 1 Infection
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 411–419, https://doi.org/10.1093/infdis/jis685
Impact of UGT1A1 Gilbert Variant on Discontinuation of Ritonavir-Boosted Atazanavir in AIDS Clinical Trials Group Study A5202
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 420–425, https://doi.org/10.1093/infdis/jis690
Immunization of Macaques With Soluble HIV Type 1 and Influenza Virus Envelope Glycoproteins Results in a Similarly Rapid Contraction of Peripheral B-Cell Responses After Boosting
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 426–431, https://doi.org/10.1093/infdis/jis696
BACTERIA
Carrier Prevalence, Secondary Household Transmission, and Long-Term Shedding in 2 Districts During the Escherichia coli O104:H4 Outbreak in Germany, 2011
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 432–438, https://doi.org/10.1093/infdis/jis702
Pneumococcal Capsular Switching: A Historical Perspective
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 439–449, https://doi.org/10.1093/infdis/jis703
In Vivo Germination of Bacillus anthracis Spores During Murine Cutaneous Infection
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 450–457, https://doi.org/10.1093/infdis/jis686
VIRUSES
Natural Killer Cell Functional Defects in Pediatric Patients With Severe and Recurrent Herpesvirus Infections
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 458–468, https://doi.org/10.1093/infdis/jis701
Protection Against Henipavirus Infection by Use of Recombinant Adeno-Associated Virus–Vector Vaccines
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 469–478, https://doi.org/10.1093/infdis/jis699
Human Papillomavirus Infection and Laryngeal Cancer Risk: A Systematic Review and Meta-Analysis
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 479–488, https://doi.org/10.1093/infdis/jis698
Group- and Genotype-Specific Neutralizing Antibody Responses Against Respiratory Syncytial Virus in Infants and Young Children With Severe Pneumonia
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 489–492, https://doi.org/10.1093/infdis/jis700
Long-Term Immunogenicity of Hepatitis A Virus Vaccine in Alaska 17 Years After Initial Childhood Series
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 493–496, https://doi.org/10.1093/infdis/jis710
Test Performance Characteristics of Anti-HEV IgG Assays Strongly Influence Hepatitis E Seroprevalence Estimates
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 497–500, https://doi.org/10.1093/infdis/jis688
Protein Energy Malnutrition Decreases Immunity and Increases Susceptibility to Influenza Infection in Mice
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 501–510, https://doi.org/10.1093/infdis/jis527
PARASITES
Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 511–519, https://doi.org/10.1093/infdis/jis709
Quinine Treatment Selects the pfnhe–1 ms4760–1 Polymorphism in Malian Patients with Falciparum Malaria
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 520–527, https://doi.org/10.1093/infdis/jis691
Impaired Skeletal Muscle Microvascular Function and Increased Skeletal Muscle Oxygen Consumption in Severe Falciparum Malaria
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 528–536, https://doi.org/10.1093/infdis/jis692
Phosphatidylserine Exposure and Surface Sugars in Two Leishmania (Viannia) braziliensis Strains Involved in Cutaneous and Mucocutaneous Leishmaniasis
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 537–543, https://doi.org/10.1093/infdis/jis689
CORRESPONDENCE
Innovative Trial Designs to Improving Tuberculosis Drug Development
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Page 544, https://doi.org/10.1093/infdis/jis704
Reply to Dodd and Proschan
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Pages 544–545, https://doi.org/10.1093/infdis/jis705
ERRATA
Redd AD et al (J Infect Dis 2012; 206:1433–42)
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Page 546, https://doi.org/10.1093/infdis/jis708
Nienabar et al (J Infect Dis 2011; 204:704–13)
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Page 546, https://doi.org/10.1093/infdis/jis707
COVER/STANDING MATERIAL
Cover
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Page NP, https://doi.org/10.1093/infdis/jis790
Editorial Advisory Board
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Page NP, https://doi.org/10.1093/infdis/jis808
Editorial Board
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Page NP, https://doi.org/10.1093/infdis/jis831
Masthead
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Page NP, https://doi.org/10.1093/infdis/jis855
Subscriptions Page
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Page NP, https://doi.org/10.1093/infdis/jis890
Table of Contents
The Journal of Infectious Diseases, Volume 207, Issue 3, 1 February 2013, Page NP, https://doi.org/10.1093/infdis/jis901
